Meta, Snowflake, PayPal And Health Care Stock On CNBC's 'Final Trades'

On CNBC’s “Halftime Report Final Trades,” Malcolm Ethridge of CIC Wealth Management named PayPal Holdings, Inc. PYPL his final trade.

On Feb. 25, PayPal issued an outlook ahead of its Investor Day event. The company reiterated guidance for an adjusted EPS growth of 6%-10% and transaction margin dollar growth, excluding the impact of interest on customer balances of growth of at least 5%. The company expects high single-digit transaction margin dollar growth and low teens+ adjusted EPS growth by 2027.

Kevin Simpson of Capital Wealth Planning said Meta Platforms, Inc. META is his top pick out of the Mag 7 names, having great free cash flow and huge margins.

On Friday, Citizens Capital Markets analyst Andrew Boone reiterated Meta Platforms with a Market Outperform rating and maintained a $750 price target.

Don’t forget to check out our premarket coverage here

Jim Lebenthal of Cerity Partners said AbbVie Inc. ABBV is a stock in a nice uptrend. It has pulled back a little bit. It has a very attractive valuation, good management and good product pipelines, he added.

AbbVie released on March 15 the final analysis of the confirmatory Phase 3 MIRASOL trial of Elahere (mirvetuximab soravtansine-gynx) in women with folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer (PROC) compared to chemotherapy.

Stephanie Link picked Snowflake Inc. SNOW, down 23% from its highs.

As per the recent news, Snowflake, on March 6, appointed Mike Gannon as chief revenue officer.

Price Action:

• PayPal shares dipped 5.4% to close at $65.15 on Friday.
• Meta shares fell 4.3% to close at $576.74 during Friday’s session.
• AbbVie shares gained 1.3% to close at $205.29 on Friday.
• Snowflake shares dipped 4.1% to settle at $150.63.

Check This Out:

Photo: Shutterstock